Short answer
Eton Pharmaceuticals, Inc. (ETON) filed an 8-K current report with the SEC on September 28, 2026 reporting Item 8.01 (Other Events). IMPAVIDO® (miltefosine) capsules launched, adding a commercial product to Eton’s portfolio.
Eton Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- IMPAVIDO® (miltefosine) capsules launched, adding a commercial product to Eton’s portfolio
- Full Eton Cares support includes $0 copay for eligible commercially insured patients
- Expanded patient assistance programs may improve access and support prescription adoption
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Eton Pharmaceuticals, Inc. 8-K filings
Get the next ETON 8-K as it lands
Follow ETON for push alerts, or ask the research agent what this filing means.